ACTRN12617001494325招募中3 期
WHO ACTION-II Trial - A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 22,589
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
终止
3 期
The WHO ACTION-I (Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns) Trial: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries to improve newborn outcomesACTRN12617000476336World Health Organization2,852
招募中
3 期
Improving newborn survival in preterm birthCTRI/2021/03/032429World Health Organization
已完成
3 期
Improving newborn survival in preterm birthCTRI/2017/04/008326World Health Organization579
已完成
3 期
Improving newborn survival in late preterm birthCTRI/2017/05/008721World Health Organization778
进行中（未招募）
不适用
A 3 month Study of Darapladib to Treat Diabetic Macular Edema (DME).Diabetic macular edema with centre involvementMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersEUCTR2011-002944-28-DEGlaxoSmithKline Research & Development Limited54